Search results
Results From The WOW.Com Content Network
v. t. e. The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV, [2] the Sinopharm COVID-19 vaccine, [3] or BIBP vaccine, [3] [4] [5] is one of two whole inactivated virus COVID-19 vaccines developed by Sinopharm 's Beijing Institute of Biological Products (sometimes written as Beijing Bio-Institute of Biological Products, [6] resulting ...
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
File:COVID-19 Vaccination Record Card CDC (8-17-2020).pdf. Size of this JPG preview of this PDF file: 710 × 599 pixels. Other resolutions: 284 × 240 pixels | 569 × 480 pixels | 725 × 612 pixels. Original file (725 × 612 pixels, file size: 52 KB, MIME type: application/pdf, 2 pages) Wikimedia Commons Commons is a freely licensed media ...
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria[6]and Covishield,[7]is a viral vector vaccine[8]produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8][9][10]Finland, Denmark, and Norway suspended the use of the Oxford ...
On 27 August 2021, India crossed the milestone of administering more than 10 million (1 crore) doses of COVID-19 vaccine in a single day, setting a new world record. Uttar Pradesh topped the list with 2.8 million doses, followed by Karnataka with 1 million doses and Maharashtra at third with 0.98 million doses.
The COVID-19 vaccination campaign in Germany began on 26 December 2020. [2] As of 16 December 2021, 60,679,186 people have received at least one dose (73% of total population), while 58,174,724 people have been fully vaccinated (70% of total population). [3] And as of 8 April 2023, 63.6 million people (76.4% of the total population) received ...
The Janssen COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID‑19 in people aged eighteen years and older. [37] [1] The vaccine is given by intramuscular injection into the deltoid muscle. The initial course consists of a single dose.
CoronaVac, also known as the Sinovac COVID-19 vaccine, [3] is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. [4] [5] It was phase III clinically trialled in Brazil, [6] Chile, [7] Indonesia, [8] the Philippines, [9] and Turkey [10] and relies on traditional technology similar to other inactivated ...